Ingrezza/Valbenazine Cost, Side effects, Dosage, Uses for Tardive Dyskinesia

The FDA granted approval of Ingrezza to Neurocrine Biosciences, Inc.

US FDA approved new drug Ingrezza that contains valbenazine as an active pharmaceutical ingredient for the treatment of tardive dyskinesia in adults. This first kind of therapy approved by US FDA as a licensed treatment for tardive dyskinesia. This drug belongs to therapeutic class termed as  vesicular monoamine transporter 2 (VMAT2) inhibitors.

Tardive dyskinesia (TD) is a severe and incurable form of dyskinesia characterized by repetitive involuntary body movements. It is termed as tardive because movements in this type of disorder are slow or belated onset. One of the major cause of this disorder is abusive use of anti psychotic drugs for a long term.

Exact underlying mechanism is still uncleared to somehow but many researcher and health care providers proposed over used of anti-psychotic drugs, smoking, neuro-degeneration, genetic predisposition, increase age are those factors that have strong correlation with this disease. Common manifestation of tardive dyskinesia are grimacing, eye blinking, lip smacking, tongue movements and lip puckering. Rapid involuntary movements of extremities may also occur. Respiratory problems like difficult breathing, grunting and respiratory depression may feel by patient suffering
tardive dyskinesia.

Ingrezza/Valbenazine is VMAT-2 inhibitor.It works by reducing the dopamine release into synaptic cleft by inhibiting VMAT2 at pre-synaptic area. VMAT2 are responsible for dopamine loading into synaptic vesicles to release them into synaptic cleft. Thus inhibition of VMAT2 creates reversible reduction of dopamine in synaptic cleft.


IngrezzaValbenazine Cost, Side effects, Dosage, Uses for Tardive Dyskinesia




Ingrezza/Valbenazine Side Effects


According to data provided by health authorities drug exhibit moderate to severe kind of side effects during clinical trials. These side effects were

  • Sleepiness 
  • Palpitation
  • Nervousness
  • Headache
  • Prolongation of QT interval
  • Cardiac Arrhythmia
  • Mental  


Ingrezza/Valbenazine Uses/Patient Information


This is the first drug approved by US FDA  (licensed treatment) for the treatment of tardive dyskinesia in adults. In pediatric patients safety profile of this drug has not yet been evaluated.


Ingrezza/Valbenazine Dosage


Standard dosage frequency of this drug is 40mg once a day but in some cases dosage frequency may increased up-to  80mg once a day orally after first week of therapy. Dose adjustment should be considered in case of liver or hepatic impairment. 


Ingrezza/Valbenazine Cost


This drug is presented to FDA in capsule dosage form but it’s potency and dosage frequency is difficult to evaluate until it appears in the market. So, we will update all the parameters of drug once, it gets available in the market.

Ocrevus/Ocrelizumab Cost, Side effects, Dosage, Uses for Multiple Sclerosis

The FDA granted approval of Ocrevus to Genentech, Inc.

US FDA approved Ocrevus that contains active pharmaceutical ingredient ocrelizumab ( monoclonal antibody) for the treatment episodal or recurring form of multiple sclerosis in adult patients. This is first drug approved for primary progressive multiple sclerosis by US FDA. This drug is administered in parenteral dosage form under the supervision of medically trained professional.

Multiple sclerosis (MS) is a kind of neuro-degenerative disease in which demyelination of nerve cells occurs. This damage imparts long lasting effects and impairs co-ordination system. Common manifestations of multiple sclerosis are vision disturbance, deceased muscle tone, difficulty in body movements, impaired sensation etc.

The exact etiological cause of multiple sclerosis is still unknown to somehow but many researchers believed that auto-immune disorders, impaired myelination, genetic predisposition and viral infections act as triggering factors in the pathogenesis of multiple sclerosis. There is no single magic bullet that can cure multiple sclerosis but it can be managed by utilizing combination of therapies. Multiple sclerosis is common in among all populations without regard to age and gender.

Ocrevus/Ocrelizumab is a monoclonal antibody used as immunotherapy. It is termed as anti-CD20 monoclonal antibody that targets CD20 marker on B lymphocytes.

OcrevusOcrelizumab Cost, Side effects, Dosage, Uses for Multiple Sclerosis


Ocrevus/Ocrelizumab Side effects

According to data obtained from health authorities drug induced side effects were moderate to severe during clinical trails. These side effects are

  • Hypersensitivity (Anaphylaxis)
  • Infusion related reactions
  • Generalized weakness
  • Dizziness
  • Hypotension
  • Rashes
  • Shortness of breath
  • Respiratory tract irritation
  • Increased risk of malignancy

Ocrevus/Ocrelizumab Uses or Patient Information

Currently, there are number of therapies available for the treatment of multiple sclerosis but US FDA approved Ocrevus for the treatment of episodal or recurring for of multiple sclerosis that is less responsive to other drugs. This first drug approved by US FDA for primary progressive multiple sclerosis.

Ocrevus/Ocrelizumab Dosage

This drug is formulated as 30mg/mL (300mg/10mL single-dose vial). However, standard dosage frequency of this drug is 300mg intravenously (IV) for the first time then after 2 weeks administer same dose. For subsequent doses inject 600mg after every 6 months.

Ocrevus/Ocrelizumab Cost

This drug is administered by your healthcare practitioner (HCP), which usually means:
  • It may comes under special items category.
  • You cannot fill this prescription in a regular pharmacy. Your doctor, hospital, or clinic will provide this  medication because of possible complications or other issues.
  • This drug is likely to be covered under your medical benefit if you have insurance.

Dupixent/dupilumab Cost, Side effects, Dosage, Uses for Eczema

The FDA granted the approval of Dupixent to Regeneron Pharmaceuticals, Inc.

US FDA approved Dupixent that contains active pharmaceutical ingredient dupilumab for the treatment of atopic dermatitis also known as eczema. This drug is administered in the parenteral dosage form to treat eczema that is not responsive to topical therapy or severe kind of eczema.

Ezema or dermatitis is a group of skin disorders that occur due to autoimmune disease, allergic reaction, skin inflammation or infection. Some common manifestations of eczema are inflammation of epidermis, blistering, skin thickening, redness of skin, severe itching and burning sensation. Most commonly affected areas are hand, foot and arms but it might affect the whole body in some cases. 

As far as etiology is concerned, many researchers believe that environmental allergens, genetic predisposition, immune system modulation and poor venous return act as triggering factors in pathogenesis of eczema but still the exact underlying cause is not yet fully known. Allergic dermatitis or eczema is most common form eczema that is common among all populations without regard to age and gender.

Dupixent/dupilumab is a monoclonal antibody used as immunotherapy. Pharmacologically, it has affinity to bind  with sub-part of interleukin-4 receptor (IL-4Rα). It causes inhibition or modulation of IL-4Rα that plays important role in inflammatory pathway and release of inflammatory mediators. In such way Dupixent reduces inflammation and severity of disease. 


Dupixent/dupilumab Cost, Side effects, Dosage, Uses for Eczema



Dupixent/dupilumab Side effects

According to According to data obtained from health authorities drug induced side effects were moderate to severe during clinical trails. Detail of these side effects are 

  • Hypersensitivity (anaphylaxis)
  • Corneal Inflammation (keratitis)
  • Scleral inflammation 
  • Conjuctivitis
  • Pain at injection site
  • Itching
  • Skin redness
  • Blisters or cold sores

Dupixent/dupilumab Uses or Patient Information

There are number topical therapies available for eczema treatment but US FDA approved Dupixent as breakthrough therapy due to promising result in eczema patients. US FDA approved this drug for eczema that is less responsive to topical therapy or severe kind of eczema.

Dupixent/dupilumab Dosage

Standard dosage strength of this drug is 300mg/2ml in a single dose Pre-filled syringe. Regular dosage frequency of this drug is 600mg (two injections of 300mg) subcutaneously (SC) in first week and then 300mg (1 injection) every other week.

Dupixent/dupilumab Cost

This drug is now available in market. According to market survey cost of single pack of dupixent ranges from 1500$ - 1700$. Each pack contains 2 pre-filled syringes of dupixent 150mg/ml. This price may variate with the passage of time so, make it confirm by visiting your nearby pharmacy before purchasing.  

Bavencio/avelumab Cost, Side effects, Dosage, Uses for skin cancer

The FDA granted accelerated approval of Bavencio to EMD Serono Inc.

 US FDA approved new drug Bavencio that contains active pharmaceutical ingredient avelumab therapeutically categorized as anti-PD-L1 IgG1 monoclonal antibody for the treatment of merkel cell carcinoma (MCC) a rare kind of skin carcinoma in adults and pediatrics.This is first kind of treatment as immunotherapy approved by US FDA for the treatment of MCC.

Though, merkel cell carcinoma is a rare kind of skin carcinoma but it is one of the most aggressive form of skin disorders. Merkel cell carcinoma is also characterized as cutaneous APUDoma. Exact underlying cause is still unclear to somehow but many researchers strongly believed that merkel cell polomavirus (MCV) is one of the leading causes of MCC. According to a statistics about 80% of merkel cell carcinoma are somewhere connected with polyomavirus while 20% of MCC cases are still unknown as  far as the underlying mechanism is concerned. This virus was first discovered in 2008 by a team of scientists at University of Pittsburgh.

Clinically this carcinoma is classified as neuroendocrine tumor and common manifestations of this tumor are small painless nodular mass projected upward and can be seen through naked eye. Mot of the times,they are brown to reddish or flesh colored tumors ranges from 0.5cm to 5cm in diameter.

Bavencio/avelumab Cost, Side effects, Dosage, Uses for skin cancer

Bavencio/avelumab Side effects

According to data obtained from health authorities this drug exhibit some side effects during clinical trails there were mild to moderate or some were severe kind of reactions. Detail of these side effects is as follows

  • Asthenia (general weakness)
  • Muscular aches
  • Nausea
  • Vomiting
  • Loss of appetite
  • Swelling in extremities
  • Edematous condition
  • Immune system hypersensitivity
  • liver inflammation
  • colitis
  • Endocrine disorders
  • Infusion related reactions

Bavencio/avelumab Uses/Prescribing Information

US FDA approved this drug for the treatment of rare but highly progressive for of skin carcinoma known as metastatic merkel cell carcinoma in adults and children having age 12 years old or more than that. This is first kind of immunotherapy approved by US FDA for the treatment of MCC.

Bavencio/avelumab Dosage

Bavencio/avelumab is administered in the form parenteral solution (intravenously). It's standard dosage frequency is 10mg/Kg after every 2 weeks in adults and children having age 12 years or more. This therapy continues for a long term to revert the progression of disease. In case of severe side effects or unacceptable toxicity drug should be discontinued and immediately consult with your health care provider.

Bavencio/avelumab Cost

According to market survey this drug is currently not available at retail pharmacies because it is recently approved by FDA and is under manufacturing process. Once, it will be available at retail outlets we will let you know about the unit cost of drug.

Xadago/safinamide Cost, Side effects, Dosage, Uses for Parkinson’s disease

The FDA granted approval of Xadago to Newron Pharmaceuticals.

US FDA approved a new drug that contains active ingredient safinamide as an adjuvant therapy for the treatment of  Parkinson disease. According to FDA this drug should be used as add on therapy when other Parkinson medications such levodopa or carbidopa does not provide adequate response or symptoms of Parkinson may get worse (off episodes).

Parkinson disease (PD) is a characterized as degenerative disorders that affects motor functions as well as activities related to central nervous system. Disease onset is slow but it remains lifetime and symptoms of parkinson disease may become severe with the passage of time. In advance stages, this disease may lead to further irreversible changes like dementia. Most common manifestations of this disease are mood changes, cognitive impairment, speech difficulty, tremors, rigidity, difficulty in movements etc. The exact underlying cause this disease is still unclear but many scientist
believed that genetic predisposition and certain environment factors play important in role in pathogenesis of Parkinson disease.

Xadago has dual mechanism of action based to increase concentration of dopamine on pre-synaptic cleft by reversible  inhibition of MAO-B and of dopamine uptake and creases the induction of glutamate release. End point of all Parkinson based medications is inducing the release of dopamine on pre-synaptic cleft, reducing the degradation of dopamine neurotransmitter or inhibition of dopamine re-uptake.


Xadagosafinamide Cost, Side effects, Dosage, Uses for Parkinson’s disease


Xadago/safinamide Side effects


According to data obtained from clinical trials of Xadago/safinamide side effects are categorized as common side effects and less common side effects.

Common Side effects

  • Nausea 
  • Vomiting
  • Difficulty in sleeping
  • Insomnia 
  • Uncontrolled movements

Less common Side effects

  • Hyperprexia
  • hypertension
  • serotonin syndrome
  • agitation
  • retinal problems

Xadago/safinamide Uses

FDA approved Xadago for the treatment of Parkinson disease in patients who experience "off episode" e.g symptoms are getting worse even after using Parkinson base medications like dopa drugs. In that case Xadago is helpful and patient can take this drug as add on therapy.

Xadago/safinamide Uses

Safinamide comes in two strength 50mg and 100mg in the form of tablet (oral dosage form). However, it's standard dosage frequency is 50mg tablet orally once in a day for 2 weeks and then dosage may increase up-to 100mg orally once a day. In case of renal or liver impairment dose titration may required.

Xadago/safinamide Cost and Dosage

According to market survey this drug is currently not available at retail pharmacies because it is recently approved by FDA and is under manufacturing process. Once, it will be available at retail outlets we will let you know about the unit cost of drug and its dosage frequency.

Noctiva/desmopressin Cost, Side effects, Dosage, Uses for Frequent Urination

Noctiva is marketed by Milford, Pennsylvania-based Renaissance Lakewood, LLC for Serenity Pharmaceuticals, LLC.

US FDA approved a new medicine noctiva with active ingredient desmopressin acetate in nasal preparation for the treatment of frequent urination or overproduction of urine during sleep time (polyuria). This is first kind of drug approved by FDA to reduce symptoms of frequent urination at night time.

Urgency to urinate at night time is termed as nocturia while the underlying cause of nocturia is over production of urine at night time is termed polyuria. Polyuria is not the only cause of nocturia it might be due to number of reasons like congestive heart failure, daibetes insipidus, diabetes mellitus, hyper active bladder, benign prostate hyperplasia, drug induced nocturia etc. So, it is the responsibility of health care provider to rule out the underlying causes of nocturia before prescribing this medicine because the drug is effective only in case of nocturia induced by nocturnal polyuria. 

Basic mechanism of action by which desmopressin reduces the urinary frequency is that it limits the amount of water in urine in renal collecting duct by binding with V2 receptors. According to pharmacokinetics, desmopressing has longer duration of action as compared to vasopression due to slow metabolic degradation. Moreover, it has better safety profile as compared to vasopressin.

Noctiva/desmopressin Cost, Side effects, Dosage, Uses for Frequent Urination

Noctiva/desmopressin Side effects

According to data received from clinical trials side effects ranges from moderate to severe. Mild to moderate side effects include nasal irritation or nasal discomfort, sneezing, nasal congestion, dizziness, hypertension. While severe kind of side effects include hyponatremia, cardiovascular events and blood pressure problem.

Noctiva/desmopressin Uses

FDA approved Noctiva for the treatment of nocturia associated nocturnal polyuria in adults. Initially start with low dose to minimize the risk of hyponatremia ( low sodium level in serum). This drug is not recommended for the treatment of nocturia in pregnant women.

Noctiva/desmopressin Dosage

Prime with 5 actuation's before initial use or re-prime with 2 actuation's if not used for more than 3 days. Patients not at increased risk for hyponatremia: 1 spray of 1.66 mcg in either nostril nightly approximately 30 min before going to bed

Noctiva/desmopressin Cost

According to market survey this drug is currently not available at retail pharmacies because it is recently approved by FDA and is under manufacturing process. Once, it will be available at retail outlets we will let you know about the unit cost of drug and its dosage frequency.

Odactra Cost, Side effects, Dosage, Uses for dust mite allergies

Odactra is manufactured for Merck, Sharp & Dohme Corp., (a subsidiary of Merck and Co., Inc., Whitehouse Station, N.J.) by Catalent Pharma Solutions Limited, United Kingdom.

US FDA approved new medicine odactra that contains allergen extract as an active ingredient. It is administered via sublingual route to treat allergic rhinitis with or without eye inflammation. This drug is suitable for people having age between 18years to 65years. Allergic rhinitis is very problem in among all populations without regard to age, gender and physical health. In some areas dust mite is the leading cause of allergic rhinitis found in the house dust, under mattress or carpets, inside the wooden material and in bed sheets. Their tiny structure allow them to hide easily around rough wooden corners, doors or anywhere they found dust.

Allergic rhinitis is basically inflammation and irritation inside the nasal passage due to inflammatory response triggered by inflammatory mediators like histamine etc. Basic mechanism of action by which odactra reduces this inflammation and irritation is desensitization to hose dust mite allergens. It is some kind of immunotherapy in which desensitization is carried out against the causative allergen. After the desensitization process patient becomes non-reactive or less reactive (hypo-allergic) to specific allergen.

Odactra Cost, Side effects, Dosage, Uses for dust mite allergies

Odactra Side effects

According to data received from clinical trails this drug may cause life threatening allergic reactions so, it's first dose must be administered under the supervision of a health care professional. According to FDA, product literature includes a boxed warning of severe allergic reactions can occur. Some other
mild to moderate kind of side effects are
  • Nausea
  • Vomiting
  • Itching in the ears and mouth
  • Swelling of the lips and tongue
  • Mucousal irritation
  • Skin allergy
  • Mild fever

Odactra Uses

FDA approved this drug for the treatment of dust mite induced allergic rhinitis. Though it can be easily administered through sublingual route but due to risk of fatal allergic reaction first dose of this drug must be administered under the supervision of health care professional.

Odactra Dosage

Standard dosage frequency of odactra for the treatment of  house dust mite (HDM) allergy or allergic rhinitis is one tablet sublingually once a day in adults. Safety profile of drug has not yet evaluated in pediatric and geriatric patients. 

Odactra Cost

According to market survey this drug is currently not available at retail pharmacies because it is recently approved by FDA and is under manufacturing process. Once, it will be available at retail outlets we will let you know about the unit cost of drug and its dosage frequency.

Siliq/brodalumab Cost, Side effects, Dosage, Uses for Psoriasis

Siliq is marketed by Bridgewater, New Jersey-based Valeant Pharmaceuticals.

U.S FDA approved new medicine siliq that contains active drug brodalumab for the treatment of psoriasis in adults. Psoriasis is a common auto-immune disorder in among all populations. Psoriasis might be of different types like plaque psoriasis, guttate psoriasis, erythrodermic psoriasis, inverse psoriasis and postular psoriasis. FDA approved Siliq for moderate to severe plaque psoriasis in adults.

Plaque psoriasis is basically a skin disorder that intense irritation and itching on skin and leaves the skin scaly or flaky along with reddish color appearance of skin. This condition may occur without regard to gender, age or ethnicity. However, it is commonly observed that people who have family history of plaque psoriasis or other are more prone to get involved in such disorder.

Siliq/brodalumab belongs to a group termed as monoclonal antibody. Basic mechanism by which brodalumab targets plaque psoriasis is that it binds to receptor interleukin-17 that generates inflammatory mediators to aggravate plaque psoriasis. Interleukin-17 does not activate after binding to brodalumab making it unable to release inflammatory mediators to make condition worse.

Siliq/brodalumab Cost, Side effects, Dosage, Uses for Psoriasis


Siliq/brodalumab  Side effects

During clinical trials drug exhibit some side effects or adverse effects experience by adult participants. These side effects were moderate to severe e.g
  • Fatigue
  • Diarrhea
  • Joint pain (arthralgia)
  • Headache
  • Injection site reactions
  • Influenza
  • low white blood cell count (neutropenia)
  • Fungal (tinea) infections
  • Throat pain (oropharyngeal pain)
  • Nausea, muscle pain (myalgia)   
  • Suicidal tendency 

Siliq/brodalumab Uses 

U.S FDA approved brodalumab for the treatment of  moderate to severe plaque psoriasis in adults. However, you healthcare provider (HCP) may recommend you a combined therapy in order to make treatment successful and better control over disease management.

Siliq/brodalumab Dosage

This drug will be available in the form of subcutaneous injection with potency of 210mg/1.5ml (single dose prefilled syringe). Standard dosage frequency of this drug is 210mg subcutaneously (SC) once in a week consecutively for 3 weeks and then 210mg subcutaneously (SC) after every two weeks.

Siliq/brodalumab Cost

Due to risk of suicidal ideation and behavior, the drug will come up with box warning and might be available through a restricted program under a Risk Evaluation and Mitigation Strategy (REMS) called the Siliq REMS Program. We will update you regarding its unit dose and dosage frequency whenever it is available in pharmacies under this program.

Emflaza/deflazacort Cost, Side effects, Dosage, Uses for Duchenne muscular dystrophy (DMD)

Emflaza is marketed by Marathon Pharmaceuticals of Northbrook, Illinois.

US FDA approved new medicine Emflaza that contains active ingredient deflazacort in oral dosage form for the treatment of Duchenne muscular dystrophy (DMD). Emflaza belongs to a therapeutic class termed as corticosteroids. Emflaza is basically a prodrug which is converted in active metabolite after its metabolism. All corticosteroids works by reducing swelling, inflammation and settling down the exaggerated immune response.

Duchenne muscular dystrophy (DMD) is a rare kind of genetic disorder that causes degeneration of muscles. Due to some genetic defect a protein termed as dystrophin does not produce in the body. The basic physiological role of dystrophin is keeping body muscles intact and healthy.

But dystrophin absence in Duchenne muscular dystrophy (DMD) makes muscle more vulnerable to degradation, degeneration and physical deterioration. Symptoms may first appear in the age of 5 years or earlier. After the onset of disease symptoms may get worst with the passage of time.

In extreme cases duchenne muscular dystrophy (DMD) may cause walking disability, cardiovascular or respiratory muscles collapse. These disabilities may appear at any time without regard to age. According to statistics this disease is more common in boys as compared to girls.

Emflaza/deflazacort Cost, Side effects, Dosage, Uses for Duchenne muscular dystrophy (DMD)

Emflaza/deflazacort Side effects

According to clinical data provided by health authorities Emflaza demonstarted a significant results over placebo. However, side effects were similar to other corticosteroids therapy. Most commonly observed side effects were as follows
  • Weight gain
  • Hair growth (hirsutism)
  • Central obesity
  • Facial puffiness (Cushingoid appearance)
  • Upper respiratory tract infection
  • Increased appetite
  • Urinary frequency
  • Cough 

Emflaza/deflazacort Uses/Prescribing information 

Though, number of corticosteroids are being used to muscular disorders like duchenne muscular dystrophy (DMD) But US FDA specifically approved Emflaza in oral dosage form for the treatment of  duchenne muscular dystrophy (DMD) in patients age 5 years and older.

 

Emflaza/deflazacort Dosage

According to medical literature provided this drug will come in following potencies 6mg, 18mg, 30mg and 36mg. Oral suspension of this drug will come up with potency of 22.75mg/mL. Drug will be administered according to body weight by following the standard of 0.9 mg/kg/day orally.

 

Emflaza/deflazacort Cost and Dosage

Emflaza is now avilable at retail outlets for end consumers. At this time, Emlfaza with potency of 6mg is only available in market in tablet form. Single pack of Emflaza has 30 tablets each tablet contains 6mg of deflazacort. Cost of single pack (30's) of Emflaza is between 7500$ to 8000$.This price may variate with the passage of time so, make it confirm by visiting your nearby pharmacy before purchasing.  

Trulance/Plecanatide Cost, Side effects, Dosage, Uses for Chronic Idiopathic Constipation (CIC)

Trulance is manufactured by New York, New York-based Synergy Pharmaceuticals Inc.

U.S FDA approved new drug Trulance that contains active ingredient plecanatide for the treatment of chronic idiopathic constipation in adults. Trulance/plecanatide belongs to a class termed as Uroguanylin analog. These agents increase the activation of guanyl cyclase C in the luminal area of intestines. Increase activation of guanyl cyclase C gives rise to fluid retention, intestinal motility and rapid intestinal transit time.

Constipation is very common problem in among all kind of populations. Constipation may occur in any person without regard to age or gender. There are number of reasons that trigger constipation problem like low or no fluid intake, impaired intestinal absorption, impaired intestinal motility, chronic disease of intestine, lack of fiber in the diet and last but not the least side effect of drugs like morphine.

Basic mechanism by which Trulance/plecanatide tones up intestinal motility is that it increases the activation of guanyl cyclase C (GC-C) in the luminal area of intestines. Such rise in activation of GCC leads to increase in cyclic guanosine monophosphate (cGMP), anion secretion,  fluid secretion, and intestinal transit. In this way it subsides the symptoms of constipation.


Trulance/Plecanatide Cost, Side effects, Dosage, Uses for Chronic Idiopathic Constipation (CIC)


Trulance/Plecanatide Side effects

According to clinical data provided by health authorities this drug is not suitable for children having age below six years. This drug withdraws some amount of water from intestines thus it will increase the risk of dehydration especially in children. In adult, following side effects were observed during clincal trails.
  • Dehydration
  • Severe Diarrhea
  • Intestinal Discomfort
  • Colic Pain
  • Increase in bowel motility
  • Headache
  • Nausea

Trulance/Plecanatide Uses or Prescribing Information

U.S FDA approved this drug for the treatment of chronic constipation of unknown origin (idiopathic) in adults. If patient is suffering from constipation due to known cause like low or no fluid intake, impaired intestinal motility or drug induced constipation then this drug should be avoided and root cause treatment should be followed. This drug is taken orally.

Trulance/Plecanatide Dosage


Standar dosage frequency of trulance in adults is 3mg once daily. However, its safety and efficacy has not yet evaluated in patients having age 6 yrs to <18 yrs

Trulance/Plecanatide Cost and Dosage


Trulance is now available at retail outlets. Single pack of this drug contains 30 tablets with potency 3mg of plecanatide per tablet. Cost of single Trulance pack ranges between 360$ to 390$. This price may variate with the passage of time so, make it confirm by visiting your nearby pharmacy before purchasing.